Market Place
Sourcing Support
All News #Library
Biotech
Acumen Pharma Showcases Brain Delivery Tech For Antibodies
02 Dec 2025 //
GLOBENEWSWIRE
JCR Pharma Launches Into Next 50 Years Of Innovation
17 Nov 2025 //
FIERCE BIOTECH
JCR Pharma Advances AAV Gene Therapy With Novel Capsid Platform
07 Oct 2025 //
PHARMIWEB
Jcr Pharma To Present At Esgct 32nd Annual Congress
30 Sep 2025 //
BUSINESSWIRE
AstraZeneca Inks Third Deal with JCR Pharma For Gene Therapies
09 Jul 2025 //
PRESS RELEASE
JCR Pharmaceuticals Enrolls in JR-141 Global Phase III Trial
02 Jul 2025 //
BUSINESSWIRE
JCR Pharmaceuticals Presents Promising CNS Uptake Data at ASGCT
16 May 2025 //
BUSINESSWIRE
JCR-Modalis Move To Next Phase For Novel Gene Therapy Research
05 Jan 2025 //
BUSINESSWIRE
JCR Pharmaceuticals Starts Phase I Trial of JR-441 in MPS IIIA
31 Oct 2024 //
BUSINESSWIRE
JCR Pharmaceuticals Presents Gene Therapy Research at Congress
23 Oct 2024 //
BUSINESSWIRE
JCR Pharmaceuticals To Present At ESGCT 31st Annual Congress
16 Oct 2024 //
BUSINESSWIRE
JCR’s Research Presentations at WORLDSymposium™ 2024 Showcase JR-141
14 Feb 2024 //
BUSINESSWIRE
JCR Pharma and Takeda Announce Discontinuation of Gene Therapy Collaboration
21 Dec 2023 //
BUSINESSWIRE
JCR Pharma Announces First Patient Dosed in a Phase I/II Trial of JR-441
10 Nov 2023 //
BUSINESSWIRE
AstraZeneca inks deal with Japanese biotech JCR in CNS indication
04 Apr 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.